Cedric Francois
CIK 1658080 · Chief Executive Officer · last filed 2026-05-14
Cedric Francois is a Chief Executive Officer who has filed 70 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for APLS, was dated May 14, 2026. Across all open-market trades the lifetime net is −$50.2M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
70
-$50.23M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Chief Executive Officer | 195,952 | $41.03 | $8.04M | -$50.23M | 70 | 2026-05-14 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −2,156,117 | $0 | EDGAR |
| 2026-03-13 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Gift (G) | — | $0 | EDGAR |
| 2026-02-05 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +8,840 | $33.2K | EDGAR |
| 2026-01-30 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +195,952 | $0 | EDGAR |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −27,192 | -$591.8K | EDGAR |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −8,182 | -$161.9K | EDGAR |
| 2026-01-15 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −10,186 | -$226.0K | EDGAR |
| 2025-08-29 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −225,000 | -$6.35M | EDGAR |
| 2025-07-18 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −10,728 | -$360.0K | EDGAR |
| 2025-07-16 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | −73,362 | -$2.53M | EDGAR |